Cargando…

Antiviral treatment for treatment-naïve chronic hepatitis B: systematic review and network meta-analysis of randomized controlled trials

BACKGROUND: Chronic hepatitis B (CHB) infection poses a significant burden to public health worldwide. Most cases are clinically silent until late in the disease course. The main goal of current therapy is to improve survival and quality of life by preventing disease progression to cirrhosis and liv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wong, William W. L., Pechivanoglou, Petros, Wong, Josephine, Bielecki, Joanna M., Haines, Alex, Erman, Aysegul, Saeed, Yasmin, Phoon, Arcturus, Tadrous, Mina, Younis, Mona, Rayad, Noha Z., Rac, Valeria, Janssen, Harry L. A., Krahn, Murray D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6699129/ https://www.ncbi.nlm.nih.gov/pubmed/31426837 http://dx.doi.org/10.1186/s13643-019-1126-1

Ejemplares similares

Disparities in a provision of in-hospital post-arrest interventions for out-of-hospital cardiac arrest (OHCA) in the elderly population—protocol for a systematic review
por: Bielecki, Joanna M., et al.
Publicado: (2016)

Estimation of fibrosis progression rates for chronic hepatitis C: a systematic review and meta-analysis update
por: Erman, Aysegul, et al.
Publicado: (2019)

Customizable optical tissue phantom platform for characterization of fluorescence imaging device sensitivity
por: Gibson, Christopher, et al.
Publicado: (2023)

A province-by-province cost-effectiveness analysis and budget impact analysis of one-time birth cohort screening of hepatitis C virus (HCV) infection in Canada
por: Wong, William W. L., et al.
Publicado: (2023)

Global adverse events reported for direct-acting antiviral therapies for the treatment of hepatitis C: an analysis of the World Health Organization VigiBase
por: Hayes, Kaleen N., et al.
Publicado: (2021)

Systematic review and network meta-analysis of stroke prevention treatments in patients with atrial fibrillation
por: Tawfik, Amy, et al.
Publicado: (2016)

Early economic evaluation of emerging health technologies: protocol of a systematic review
por: Pham, Ba’, et al.
Publicado: (2014)

Identification of HCV Resistant Variants against Direct Acting Antivirals in Plasma and Liver of Treatment Naïve Patients
por: Raj, V. Stalin, et al.
Publicado: (2017)

The impact of expanded access to direct acting antivirals for Hepatitis C virus on patient outcomes in Canada
por: Chu, Cherry, et al.
Publicado: (2023)

Comparative effectiveness of the different components of care provided in heart failure clinics—protocol for a systematic review and network meta-analysis
por: Slater, Morgan, et al.
Publicado: (2019)

Direct Acting Antiviral Agents in Korean Patients with Chronic Hepatitis C and Hemophilia Who Are Treatment-Naïve or Treatment-Experienced
por: Lee, Hyun Woong, et al.
Publicado: (2017)

Tumor characteristics of hepatocellular carcinoma after direct-acting antiviral treatment for hepatitis C: Comparative analysis with antiviral therapy-naive patients
por: Fouad, Magdy, et al.
Publicado: (2021)

A Systematic Review of the Cost-Effectiveness of Cleft Care in Low- and Middle-Income Countries: What is Needed?
por: Chung, Karen Y., et al.
Publicado: (2022)

Accessing hepatitis C direct acting antivirals among people living with hepatitis C: a qualitative study
por: Antoniou, Tony, et al.
Publicado: (2023)

Risk score model for the development of hepatocellular carcinoma in treatment-naïve patients receiving oral antiviral treatment for chronic hepatitis B
por: Sohn, Won, et al.
Publicado: (2017)

Correction: Accessing hepatitis C direct acting antivirals among people living with hepatitis C: a qualitative study
por: Antoniou, Tony, et al.
Publicado: (2023)

Psychiatric treatment considerations with direct acting antivirals in hepatitis C
por: Sockalingam, Sanjeev, et al.
Publicado: (2013)

Cognitive Impairment In Treatment-Naïve Bipolar II and Unipolar Depression
por: Mak, Arthur D. P., et al.
Publicado: (2018)

Understanding factors critical to the implementation of ehealth in chronic disease management: a realist review protocol
por: Shahid, Nida, et al.
Publicado: (2021)

Ocular Surface Changes in Treatment-Naive Thyroid Eye Disease
por: Liao, Xulin, et al.
Publicado: (2023)

Global Utilization Trends of Direct Acting Antivirals (DAAs) during the COVID-19 Pandemic: A Time Series Analysis
por: Shakeri, Ahmad, et al.
Publicado: (2021)

COLD-PCR Method for Early Detection of Antiviral Drug-Resistance Mutations in Treatment-Naive Children with Chronic Hepatitis B
por: Phung, Thuy Thi Bich, et al.
Publicado: (2020)

Diagnostic performance of elastography on liver fibrosis in antiviral treatment-naive chronic hepatitis B patients: a meta-analysis
por: Mingkai, Li, et al.
Publicado: (2022)

Analysis of antiviral efficacy after switching from brand to generic entecavir in patients with treatment-naïve chronic hepatitis B
por: Hsu, Po-Ke, et al.
Publicado: (2022)

Raltegravir in treatment naïve patients
por: Cossarini, F, et al.
Publicado: (2009)

Safety, Pharmacokinetics, and Antiviral Activity of a Novel HIV Antiviral, ABX464, in Treatment-Naive HIV-Infected Subjects in a Phase 2 Randomized, Controlled Study
por: Steens, Jean-Marc, et al.
Publicado: (2017)

Antiviral Treatments
por: Ison, Michael G.
Publicado: (2017)

A Cost-Effectiveness Analysis of Shortened Direct-Acting Antiviral Treatment in Genotype 1 Noncirrhotic Treatment-Naive Patients With Chronic Hepatitis C Virus
por: Fawsitt, Christopher G., et al.
Publicado: (2019)

Publicly Funded Oral Chronic Hepatitis B Treatment Patterns in Ontario over 16 Years: An Ecologic Study
por: Tadrous, Mina, et al.
Publicado: (2018)

Comparative Effectiveness of the Core Components of Cardiac Rehabilitation on Mortality and Morbidity: A Systematic Review and Network Meta-Analysis
por: Kabboul, Nader N., et al.
Publicado: (2018)

Genetic Polymorphisms of Vitamin D Pathway Predict Antiviral Treatment Outcome in Slow Responder Naïve Patients with Chronic Hepatitis C
por: Falleti, Edmondo, et al.
Publicado: (2013)

The truth of the matter: will immune-tolerant chronic hepatitis B patients benefit from antiviral treatment?
por: Jeng, Wen-Juei, et al.
Publicado: (2023)

Persistence of Antipsychotic Treatment in Elderly Dementia Patients: A Retrospective, Population-Based Cohort Study
por: Mast, Gavin, et al.
Publicado: (2016)

A Practical Model Evaluating Antiviral Cytokines by Natural Killer Cells in Treatment Naïve Patients with Chronic Hepatitis B Virus Infection
por: Li, Xiaoyan, et al.
Publicado: (2017)

Retraction Note: Analysis of antiviral efficacy after switching from brand to generic entecavir in patients with treatment-naïve chronic hepatitis B
por: Hsu, Po-Ke, et al.
Publicado: (2022)

Efficacy and safety of abacavir/lamivudine plus rilpivirine as a first-line regimen in treatment-naïve HIV-1 infected adults
por: Ho, Sharlene, et al.
Publicado: (2020)

Predicting the Impact of Adverse Events and Treatment Duration on Medical Resource Utilization-Related Costs in Hepatitis C Genotype 1 Treatment-Naïve Patients Receiving Antiviral Therapy
por: Akpo, Essè Ifèbi Hervé, et al.
Publicado: (2015)

WHAT’S OLD IS NEW: USING ARTIFICIAL INTELLIGENCE TO ACCELERATE DISCOVERY OF NEW TREATMENTS
por: Marras, Connie, et al.
Publicado: (2019)

Prevalence and predictors of primary nonadherence to medications prescribed in primary care
por: Zeitouny, Seraphine, et al.
Publicado: (2023)

Increasing antiviral treatment uptake improves survival in patients with HBV-related HCC
por: Hui, Vicki Wing-Ki, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_69vqeccfd7c1jmhq477411hnm3